Novo's Wegovy has lost market share to Eli Lilly's Zepbound, and a new head-to-head study found that Zepbound patients lost ...

Some consumers take tiny doses of Ozempic and other GLP-1 drugs or stretch out doses to cut costs and side effects.

Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.

According to the Market Research Blog, "the total U.S. weight loss market is estimated to have grown to a historic peak of ...